Form 8-K - Current report:
SEC Accession No. 0001437749-25-022890
Filing Date
2025-07-17
Accepted
2025-07-17 09:24:36
Documents
15
Period of Report
2025-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250715_8k.htm   iXBRL 8-K 52594
2 EXHIBIT 10.1 ex_838806.htm EX-10.1 613622
3 EXHIBIT 99.1 ex_839148.htm EX-99.1 12075
  Complete submission text file 0001437749-25-022890.txt   970626

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wint-20250716.xsd EX-101.SCH 3579
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250716_def.xml EX-101.DEF 11807
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250716_lab.xml EX-101.LAB 15858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250716_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT wint20250715_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 251129059
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)